Oracle unveiled its Oracle Health Oncology EHR at the Oracle Health and Life Sciences Summit in Orlando, Fla. The cancer-specific EHR is built on the company’s AI-powered ambulatory EHR.
The system brings together oncology workflows, AI-driven clinical intelligence drawn from multiple data sources and connected patient information, according to a Sept. 23 news release shared with Becker’s. Oracle said it designed the system to support care from diagnosis through treatment, and follow-up across inpatient and outpatient settings, with embedded AI agents and clinical decision support.
An AI-powered assistant for oncologists is expected to generate patient snapshots and pre-visit summaries, help with tumor board preparation and guideline-grounded treatment planning, and carry clinicians’ decisions into orders, referrals, documentation and coding.
Planned capabilities include:
- A chronological timeline of cancer-related diagnoses and treatments
- Connected worklists that let nurse navigators coordinate care from diagnosis through survivorship
- Precision oncology insights that unify genomic, radiology, pathology, laboratory, pharmacy and social determinants of health data
- Chemotherapy and immunotherapy regimen planning with lifetime cumulative-dose calculations and mobile ordering
“Care teams should not be slowed down by fragmented information, lack of clinical insights, and antiquated technology that forces the patient to search for and recount their history repeatedly, risking critical missed details,” said Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences.
Ms. Verma said the EHR is designed to pull the patient’s story together and provide personalized treatment recommendations.
Oracle said the oncology assistant is part of a broader plan for role-based AI assistants that serve nurses, patients, care coordinators, researchers and the wider multidisciplinary cancer care team.
